Pharmaceutical Suspension
| Strength | 25 mg/mL |
| Packaging Size | 8 ml |
| Brand | Survanta |
| Prescription/Non prescription | Non prescription |
| Shelf life | 24 months |
| Manufacturer | Abbvie |
| Injection Site | Intramuscular |
| Composition | Beractant |
| Treatment | Treatment of Respiratory Distress Syndrome |
Survanta is indicated for treatment of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in new born premature infants with a birth weight of 700g or greater.
Additional Information:
- Delivery Time: 3 days
View Complete Details
- Developed and Managed by IndiaMART InterMESH Limited







